Skip to main content
. Author manuscript; available in PMC: 2022 Jul 27.
Published in final edited form as: Nat Microbiol. 2022 Jan 27;7(2):262–276. doi: 10.1038/s41564-021-01050-3

Extended Data Fig. 7. Peptide fragments are increased in active UC patients and Bacteroides protease enriched patients.

Extended Data Fig. 7

a, Comparison of peptide fragments identified in patients with varying abundance of Bacteroides proteases. Overproducers from UC cohort 1 had increased peptide fragments in comparison to other patients (Two-tailed t-test P=3.5E-2). Data was derived from n=8, 9, 23 UC cohort 1 samples and n=6, 6, 49 UC cohort 2 samples from patients classified as underproducer, overproducer and other respectively. b, Peptide termini indicate unique proteolysis of human and microbial proteins. The frequency of each amino acid within the N and C terminus of human and de-novo peptides was compared to either the human proteome or the total amino acid content of de novo peptides. The Y-axis represents the percent difference of each residue and the letter indicates the amino acid associated with the difference. The N and C terminus are shown separately and each residue is colored by chemical property (Green = polar, Black = Hydrophobic, Red = Acidic, Blue = Basic, Purple = Neutral). c, Peptide fragment identification comparison by disease activity in UC cohort 1. Boxplots with a two-tailed t-test p-value is shown (P=4.7E-3). Data was derived from n=18, 12, 10 patient samples with low moderate or high disease activity respectively. d, Peptide fragment identification comparison by disease and disease activity state for cohort 2 samples. Boxplots are shown with overlaid two-tailed t-test p-values. Data was derived from n=19 healthy controls, n=39, 30, 12 UC samples, and n=64, 30, 8 CD samples from patients of low, moderate and high activity respectively. Boxplots in (a,c,d) are defined by the median, quartiles and 1.5x inter-quartile range.